Popular Articles
Natural Remedies

Counselling To Overcome Challenges, UK
Counsellors from around the world will meet to discuss their role in helping people deal with social, cultural, economic and natural challenges at the 2009 International Association for Counselling (IAC) Counference organised by the British Association for Counselling and Psychotherapy (BACP).
generic viagra online
Gilead Sciences, Tibotec To Develop Second Once-Daily HIV Treatment
Foster City, Calif.-based Gilead Sciences on Thursday said it has entered into a license and collaboration agreement with Johnson and Johnson subsidiary Tibotec Pharmaceuticals for the development and commercialization of a new once-daily fixed-dose treatment for HIV, the San Francisco Business Times reports. The FDA approved the first once-daily HIV treatment Atripla in 2006 (7/16). The new antiretroviral drug would contain Tibotec"s experimental non-nucleoside reverse transcriptase inhibitor, known as TMC278, and Gilead"s combination pill, Truvada. Kevin Young, head of commercial operations at Gilead "said the new combination pill, along with Gilead"s experimental "quad" pill, will be used for newly-diagnosed patients, with physicians reluctant to change therapy for patients who are responding well to Atripla," Reuters reports. Young said the drug is expected to reach the market in 2011 (Beasley, 7/16).
News of the day
Ongoing Study Shows That Endovascular Therapy Is Associated With High Cure Rate For Childhood Eye Cancer
Expanded results of a study conducted on children with eye cancer (retinoblastoma) shows that chemotherapy delivered through endovascular (through the vessel) means not only successfully cures the cancer in a majority of cases, but achieves this cure with preserved vision. Study outcomes were presented this week at the Society of NeuroInterventional Surgery (SNIS) 6th Annual Meeting in Boca Raton, FL by lead author Pierre Gobin, Professor of Radiology in Neurosurgery and Neurology at the Weill Cornell Medical Center at New York Presbyterian Hospital in New York City.
Medical Devices

BVA Asks Defra To Abandon Separation Of Animal Health From Animal Welfare

The British Veterinary Association (BVA) has called on Defra to abandon its plans for a new animal health body that will give responsibility for animal health to an independent board and leave responsibility for animal welfare with ministers. The BVA has also expressed deep concerns over the confusion caused by the new structure that could lead to delays in dealing with outbreaks of disease across the UK. In its response to the Defra consultation on responsibility and cost sharing, which closed today (Tuesday 30th June), the BVA highlighted the following issues Animal welfare: The welfare of animals is inextricably linked to their health and the BVA does not support Defra"s proposal to separate the two. Any new body responsible for animal health must also be responsible for animal welfare. Disease control: The lack of clarity in the proposals over the roles of the Chief Veterinary Officers, the Board, and Ministers may compromise the UK"s ability to respond effectively to major outbreaks of notifiable disease, such as BSE, bluetongue, avian influenza and foot and mouth disease. Anything that causes confusion in decision making could have disastrous consequences for the farming and the rural economy. Non-livestock animals: The implications of the new body for species including horses, companion animals and zoos/wildlife establishments are not described or considered. It is essential to ensure they are not overlooked or sidelined in a body with a Board set up around livestock. Funding: The Government must continue to seek to improve animal health and welfare and maintain its financial commitment to disease control. In a new partnership arrangement the costs of diseases control must not simply be transferred to the industry. Any cost sharing arrangements must also provide industry with an incentive for action to improve their practice and reward those that achieve good animal health and welfare outcomes and penalise those that refuse to adopt industry accepted norms. Competitiveness of English agriculture: The competitiveness of English agriculture could be jeopardised in relation to other EU Member States and other parts of the UK if these proposals are brought in before European-wide proposals are announced in 2011. Commenting, BVA President Nicky Paull said "We"re asking Defra to go back to the drawing board on responsibility and cost sharing. While we agree with the principle of sharing responsibility for managing disease with industry, we believe this is the wrong way to achieve it. "Every vet knows that you cannot consider an animal"s health or welfare in a bubble - the two are intrinsically connected. "Leaving animal welfare issues with ministers who have one eye on the political agenda risks some important issues slipping through the net." Mrs Paull added "The BVA is also very concerned that the new structure puts at risk the clear structures and single line of command essential in the event of a major disease outbreak. We know from experience that any delay in communication and decision-making in the face of foot and mouth, BSE or avian influenza comes with a hefty price tag. "Instead of focusing on structures that confuse the process, Defra should concentrate on creating a real partnership between government, industry and the veterinary profession. We hope Defra will take our constructive criticism on board so that we can make responsibility and cost sharing work for everyone." Notes 1. Defra consultation "Consultation on a new independent body for animal health: A modern governance and funding structure for tackling animal diseases" British Veterinary Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):